Category: Patent Litigation
-
Lupin granted win against Vertex in Delaware over cystic fibrosis drug patents
Lupinâs generic version of Vertexâs cystic fibrosis treatment Kalydeco does not infringe the latterâs patents, Judge Stephanos Bibas of the Third Circuit has ruled.
-
UPC Hamburg finds HMD unwilling after rejecting pool route for bilateral licensing
The UPCâs Hamburg Local Division held that a FRAND-compliant pool offer can satisfy a SEP holderâs obligations under Huawei v. ZTE, while setting conditions for when an implementer may insist on bilateral licensing.
-
Guardant Health ordered to pay TwinStrand Biosciences and University of Washington $245M in Delaware dispute over DNA sequencing patents
The co-plaintiffs were originally awarded $83.4 million by a District of Delaware jury in November 2023.
-
InterDigital expands UPC litigation against Disney, says VP9 workaround still infringes its patents
InterDigital has filed new claims at the UPC targeting Disneyâs use of VP9 for 4K streaming, arguing the codec still infringes its patents despite seven injunctions already won worldwide.
-
Opinion: Access Advance’s view on the UK Supreme Court’s Tesla v. InterDigital & Avanci decisionÂ
The UK Supreme Courtâs decision in Tesla v. InterDigital & Avanci recognizes, as have courts around the world, that patent pools which are procompetitive are efficient, market-driven mechanisms that drive rapid and widespread adoption of standardized technology, enabling better consumer experience while ensuring interoperability. Indeed, that widely accepted truth is an important driver of the UK Supreme Courtâs…
-
FTC urges Fourth Circuit to reject Amgen plea to shield Roche patent acquisition: deal âthreatens to upendâ long-settled antitrust framework
The U.S. Federal Trade Commission has filed an amicus brief in an antitrust case between CareFirst and Amgen, urging the Fourth Circuit to reject Amgenâs bid to shield its acquisition of pending patent applications from antitrust scrutiny, as such procurements violate the Sherman Act and are not immunized by the Noerr-Pennington doctrine.
-
Valtrus Innovations expands data center-focused campaign with multiple district court complaints asserting former HPE patents
Meanwhile, Starbucks’ declaratory judgment and anti-troll actions against Valtrus in Washington have been terminated.
-
Canadian Solar, Maxeon settle U.S. patent dispute
The Eastern District of Texas has dismissed Maxeonâs suit against Canadian Solar with prejudice, while the Federal Circuit has vacated the relevant portion of a PTAB decision relating to Maxeon’s remaining claim, resolving the case in Canadian Solarâs favor.
-
Zoom gets dialed in to Delaware suit as PulseLink files additional complaint over patents acquired from Avaya
It’s the second complaint that PAE PulseLink Systems LLC has filed against Zoom, following one in the Eastern District of Texas earlier this year.
-
Munich court consolidates FRAND framework for SEP licensing disputes
The Munich I Regional Courtâs new FRAND guidelines consolidate the 7th Civil Chamberâs approach to licensing willingness, implementer conduct and substantive review of SEP-holder offers into a single roadmap for future disputes.